Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500211 · ClinicalTrials.gov registry record · Phase 4
Post-Op Lidocaine Patch
A Phase 4 study of Pain, Postoperative, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03500211: Completed Phase 4 study of Pain, Postoperative, sponsored by Oregon Health and Science University.
NCT03500211 is a Phase 4 study of Pain, Postoperative that has completed, run by Oregon Health and Science University. The registered enrollment target is 50 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03500211, a Phase 4 study of Pain, Postoperative, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.
Primary Outcome
To determine if lidocaine patch is superior to placebo as an adjunctive therapy for acute postoperative pain. Average pain score in women who have undergone cesarean delivery at 12 hours postoperatively. Measured using a Visual Analog Scale (VAS), a scale which measures pain from 0 to 100 with 0="no pain" and 100="the worst pain you have ever felt".
Conditions Studied
Interventions
- DRUG Lidoderm 5 % Topical Patch
- OTHER Sham Topical Patch
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-03-13 |
| Est. Completion | 2019-03-01 |
| Phase | Phase 4 |
What the finished NCT03500211 record still lists
NCT03500211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Lidoderm 5 % Topical Patch is the first listed.
NCT03500211 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT03500211 about?
NCT03500211 is a clinical study titled "Post-Op Lidocaine Patch". Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.
What is the current status of trial NCT03500211?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2018-03-13. Estimated completion is 2019-03-01.
What conditions does trial NCT03500211 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT03500211?
The interventions under investigation include: Lidoderm 5 % Topical Patch (DRUG), Sham Topical Patch (OTHER).
Who is sponsoring clinical trial NCT03500211?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03500211 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03500211's enrollment target sits among peer trials
50 90th of 113 higher than 20 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI